Literature DB >> 6855403

Cavernous sinus thrombophlebitis secondary to sphenoid sinusitis.

R A Sofferman.   

Abstract

Cavernous sinus thrombosis is a serious life threatening condition which usually results from midfacial skin infections. Preantibiotic era mortality rates of 80% have improved markedly because of an early awareness of the condition and prompt initiation of parenteral antibiotics. Sphenoid sinusitis is an uncommon associated cause of cavernous sinus infection and is itself a rare and elusive clinical problem. A case of sphenoid sinusitis and concurrent cavernous sinus thrombophlebitis is presented to highlight the clinical diagnostic considerations with special emphasis on bilateral eye signs as indicators of the impending thrombophlebitic process.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6855403     DOI: 10.1288/00005537-198306000-00017

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  6 in total

1.  The spectrum of cavernous sinus and orbital venous thrombosis: a case and a review.

Authors:  P F Lai; M D Cusimano
Journal:  Skull Base Surg       Date:  1996

Review 2.  Septic Cavernous Sinus Thrombosis: Case Report and Review of the Literature.

Authors:  Dinushi Weerasinghe; Christian J Lueck
Journal:  Neuroophthalmology       Date:  2016-10-19

3.  Cavernous sinus thrombosis of nasal origin in children.

Authors:  Saurabh Varshney; Manu Malhotra; Pratima Gupta; Priyanka Gairola; Navjot Kaur
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2014-11-27

4.  Early cavernous sinus thrombosis following unilateral pansinusitis in a child.

Authors:  Ajay Mallick; Som Dutt Pathak; Sandeep Shankar; Alok Sati
Journal:  BMJ Case Rep       Date:  2015-04-26

5.  Pachymeningitis presenting feature of posterior sinus infection.

Authors:  A Leiberman; F Tovi; M Hirsch
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

6.  Sphenoid sinusitis.

Authors:  R A Hill; L N Johnson; R Parnes
Journal:  J Natl Med Assoc       Date:  1991-01       Impact factor: 1.798

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.